To discuss the effective treatment measures of corneal neovascularization.
探讨角膜新生血管的有效治疗措施。
Corneal neovascularization is induced in the effects of pathological factors.
角膜在病理因素的作用下产生新生血管。
The image shown demonstrates the effects of a severe chemical injury with early corneal neovascularization.
如图所示为严重化学伤后早期发生的角膜新生血管形成。
Corneal neovascularization (CNV) usually occurs in infectious diseases, inflammation, trauma or corneal operations.
角膜新生血管(CNV)多见于感染、炎症、外伤或角膜手术后。
Not only does corneal neovascularization seriously affect vision, but also leads to corneal transplantation failure.
角膜新生血管不但严重影响视力，而且导致角膜移植手术的失败。
Corneal neovascularization (CNV) is one of the most causes of corneal blindness and the high-risk factor of corneal graft rejective reaction.
角膜新生血管是角膜盲的主要原因，亦是角膜移植排斥反应的高危因素。
DATA SYNTHESIS: corneal neovascularization is the common pathological changes as corneal injury, inflammation and infection and many diseases.
资料综合：角膜新生血管是角膜外伤、炎症、感染等多种疾病共同的病理改变。
Objective to observe the expression of TFPI-2 in corneal keratocytes in vitro and investigate the experimental basis for curing corneal neovascularization with gene-therapy.
目的探讨角膜基质细胞组织因子途径抑制物2 (TFPI - 2)的表达情况，为角膜新生血管的基因治疗提供方法。
Objective To investigate the correlation between corneal neovascularization (CNV) in rat after cautery with acid and the defect in epithelium, the infiltrating of leucocytes.
目的研究大鼠角膜酸烧伤后新生血管形成与角膜上皮缺损和白细胞渗出的关系。
Vascular endothelial growth factor and pigment epithelium-derived factor are most enhancing factor and strongest inhibitory factor of corneal neovascularization(CNV)at present.
血管内皮生长因子和色素上皮细胞衍生因子是目前发现的作用最强的角膜新生血管形成促进因子和抑制因子。
Recently, massive studies of the treatments to corneal neovascularization have being gone in photodynamic therapy, medicine and operation, et al. and its development has progressed largely.
近年来，国内外对角膜新生血管的治疗在药物治疗、光动力疗法、眼表重建术等方面做了大量的研究，并取得迅猛发展。
Mark Prausnitz says the microneedles were successful in treating both glaucoma and the growth of unwanted blood vessels around the cornea. The condition is called corneal neovascularization.
马克。普罗斯尼茨说这种微针头对治疗青光眼和角膜新生血管都很成功。
In recent years, the treatment of corneal neovascularization has achieved rapid development both at home and abroad, but corneal neovascularization is still the most common cause of blindness.
近年来，国内外对角膜新生血管的治疗取得迅猛发展，但角膜新生血管依然是目前最常见的致盲原因之一。本文综述了近年来角膜新生血管的药物治疗进展。
In recent years, the treatment of corneal neovascularization has achieved rapid development both at home and abroad, but corneal neovascularization is still the most common cause of blindness.
近年来，国内外对角膜新生血管的治疗取得迅猛发展，但角膜新生血管依然是目前最常见的致盲原因之一。本文综述了近年来角膜新生血管的药物治疗进展。
应用推荐